Benign Prostatic Hyperplasia News

INDIANAPOLIS, Feb. 7, 2012 /PRNewswire/ -- Eli Lilly and Company announced today that a Phase III study, published online by European Urology, showed both CialisA and tamsulosin significantly improved scores on the International Prostate Symptom Score , compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia .

The Food and Drug Administration has now approved the erectile dysfunction drug tadalafil to treat the signs and symptoms of benign prostatic hyperplasia and as a treatment for BPH and erectile dysfunction when they occur together.

A study published Online First in The Lancet has found that a common medication used to treat enlargement of the prostate, may also reduce the need for treatments that pose risks of incontinence and impotence and delay growth of early-stage prostate cancer.

Benign prostatic hyperplasia is the abnormal growth of prostate cells that can be terminated by the use of Dr.

Brian Lindshield, assistant professor of human nutrition, is helping men make more informed diet decisions by studying foods and dietary supplements that may reduce the risk of prostate cancer.

DEAR DR. DONOHUE: I am 49 and have been diagnosed with prostatitis. I was given tamsulosin as well as antibiotics.

New Thermobalancing Therapy terminates the progression of benign prostatic hyperplasia , states Fine Treatment.

Fine Treatment recommends a new Thermobalancing Therapy as an effective prostate treatment for men aged 50 and over.

The possibility to treat even enormously enlarged prostate at home by new Thermobalancing Therapy is reported by Fine Treatment.

Fine Treatment recommends new Thermobalancing Therapy for the treatment of Benign Prostatic Hyperplasia that eliminates the pathological factor by improving the blood flow inside the prostate tissue.